Longitudinal monitoring of circulating tumor DNA to detect relapse early and predict outcome in early breast cancer.
Garcia-Murillas I, Cutts RJ, Walsh-Crestani G, Phillips E, Hrebien S, Dunne K, Sidhu K, Daber R, Hubert B, Graybill C, DeFord PM, Wooten DJ, Zhao J, Ellsworth RE, Johnston SRD, Ring A, Russell S, Evans A, Skene A, Wheatley D, Smith IE, Korn WM, Turner NC.
Garcia-Murillas I, et al. Among authors: hubert b.
Breast Cancer Res Treat. 2024 Oct 18. doi: 10.1007/s10549-024-07508-2. Online ahead of print.
Breast Cancer Res Treat. 2024.
PMID: 39424680